Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection.
Jacobson SG; Acland GM; Aguirre GD; Aleman TS; Schwartz SB; Cideciyan AV; Zeiss CJ; Komaromy AM; Kaushal S; Roman AJ; Windsor EA; Sumaroka A; Pearce-Kelling SE; Conlon TJ; Chiodo VA; Boye SL; Flotte TR; Maguire AM; Bennett J; Hauswirth WW; Molecular Therapy: The Journal Of The American Society Of Gene Therapy, 2006, vol. 13, issue 6, p 1074, ISSN 15250016. ISBN 15250016.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef